Targeting BCL2L2 by shRNA induced apoptosis in lymphoma cell lines and higher levels of BCL2L2 in patients with B lymphocyte leukemia are associated with lower overall survival [40]. The gene discussed is BCL2L2; the disease is lymphoma.